Aktie A0LEJ1 VELOXIS PHARMACEUTICALS A/S
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Veloxis Pharmaceuticals A/S CBOE EUROPE EQUITIES

Aktien

A0LEJ1

DK0060048148

0IVI

Schlusskurs CBOE EUROPE EQUITIES
Andere Börsenplätze
- DKK - Intraday Chart für Veloxis Pharmaceuticals A/S
2022 Veloxis Pharmaceuticals gibt die Verabreichung des ersten Patienten durch den Partner Xenikos in der globalen Phase-3-Studie zur Evaluierung von T-Guard(R) bei Patienten mit steroidrefraktärer akuter Graft-Versus-Host-Krankheit (SR-aGVHD) bekannt CI
2019 Transcript : Asahi Kasei Pharma Denmark A/S, Veloxis Pharmaceuticals A/S - M&A Call

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Veloxis Pharmaceuticals Announces Dosing of the First Patient by partner Xenikos in the Global Phase 3 Study Evaluating T-Guard(R) in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)
Scandion Oncology A/S : appoints Johnny Stilou as new CFO
Veloxis Pharmaceuticals, Inc entered into a global license agreement to acquire Worldwide Rights to FR104 from OSE Immunotherapeutics SA.
Veloxis Pharmaceuticals A/S : Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020
Veloxis Pharmaceuticals A/S Announces Board Appointments
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from OMX Nordic All-Share Index
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index
Veloxis Pharmaceuticals A/S : Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S
Veloxis Pharmaceuticals A/S : - Notice to Convene Extraordinary General Meeting
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S : - Major Shareholder Notifications
Veloxis Pharmaceuticals A/S : Notice to Convene Extraordinary General Meeting
Veloxis Pharmaceuticals A/S : Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S: Major Shareholder Notifications
Veloxis Pharmaceuticals A/S : Increases Share Capital in Connection with Asahi Kasei Pharma Denmark's Exercise of Warrants Acquired under the Public Tender Offer
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
Veloxis Pharmaceuticals A/S : - Reporting of Managers and Closely Associated Persons Transactions in Veloxis-Shares and Financial Instruments Linked Hereto
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0LEJ1 Aktie
  4. A0LEJ1 Aktie
  5. Nachrichten Veloxis Pharmaceuticals A/S
  6. Andere Sprachen